{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:56Z","timestamp":1792176476629,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ajog.2017.01.040","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T13:48:29Z","timestamp":1486475309000},"page":"529.e1-529.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Maternal buprenorphine treatment and fetal neurobehavioral development"],"prefix":"10.1016","volume":"216","author":[{"given":"Lauren M.","family":"Jansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Tuten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendree E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine A.","family":"Milio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Voegtline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"DiPietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.01.040_bib1","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome an associated health care expenditures United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2017.01.040_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.01.040_bib3","series-title":"Treatment Episode Data Set (TEDS): 2000-2010. National Admissions to Substance Abuse Treatment Services. DASIS Series S-61, HHS Publication No. (SMA) 12-4701","year":"2012"},{"key":"10.1016\/j.ajog.2017.01.040_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome \u2013 28 states, 1999-2013","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2017.01.040_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"key":"10.1016\/j.ajog.2017.01.040_bib6","series-title":"Guidelines for the identification and management of substance use and substance use disorders in pregnancy","year":"2014"},{"key":"10.1016\/j.ajog.2017.01.040_bib7","unstructured":"American Society of Addiction Medicine (ASAM). The ASAM National Practice Guidelines for the use of medications in the treatment of addiction involving opioid use. Available at: http:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guideline-supplement.pdf. Accessed March 10, 2017."},{"key":"10.1016\/j.ajog.2017.01.040_bib8","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.01.040_bib9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1467-8624.2009.01384.x","article-title":"Prenatal antecedents of newborn neurological maturation","volume":"81","author":"DiPietro","year":"2010","journal-title":"Child Dev"},{"key":"10.1016\/j.ajog.2017.01.040_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.ajog.2017.01.040_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before or after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2017.01.040_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0740-5472(96)00070-0","article-title":"Pregnancy and Addiction: A Comprehensive Care Model","volume":"13","author":"Jansson","year":"1996","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.ajog.2017.01.040_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.07.001","article-title":"Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument","volume":"105","author":"Tompkins","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajog.2017.01.040_bib14","first-page":"277","article-title":"Doppler recordings of fetal movement: clinical correlation with real-time ultrasound","volume":"74","author":"Besinger","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.01.040_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0378-3782(95)01704-6","article-title":"Development of fetal movement-fetal heart rate coupling from 20 weeks through term","volume":"44","author":"DiPietro","year":"1996","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2017.01.040_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1471-0528.1999.tb08305.x","article-title":"Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy","volume":"106","author":"Locatelli","year":"1999","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.01.040_bib17","first-page":"99","article-title":"Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection","volume":"81","author":"Paternoster","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.01.040_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.21111","article-title":"Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population based study","volume":"43","author":"Ropponen","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajog.2017.01.040_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinre.2016.07.004","article-title":"Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis","volume":"41","author":"Wiiarnpreecha","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ajog.2017.01.040_bib20","first-page":"611","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.01.040_bib21","first-page":"1","article-title":"Studies in fetal behavior: revisited, renewed and reimagined","volume":"80","author":"DiPietro","year":"2015","journal-title":"Monogr Soc Res Child Dev"},{"key":"10.1016\/j.ajog.2017.01.040_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0890334416663198","article-title":"Maternal buprenorphine maintenance and lactation","volume":"32","author":"Jansson","year":"2016","journal-title":"J\u00a0Hum Lact"},{"key":"10.1016\/j.ajog.2017.01.040_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","article-title":"Methadone maintenance and breastfeeding in the neonatal period","volume":"121","author":"Jansson","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2017.01.040_bib24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.arcmed.2007.06.007","article-title":"Effects of smoking and fetal hypokinesia in early pregnancy","volume":"38","author":"Habek","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ajog.2017.01.040_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1471-0528.1984.tb05892.x","article-title":"Smoking in pregnancy: effects on mother and fetus","volume":"91","author":"Kelly","year":"1984","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817301758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817301758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:13:18Z","timestamp":1757589198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817301758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0002937817301758"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.01.040","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal buprenorphine treatment and fetal neurobehavioral development","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.01.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}